Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about DES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
DES is a gene implicated in neurodegeneration research. Key relationships include: activates, implicated in, associated with. Associated with ALS, Aging, Als. Connected to 115 entities in the SciDEX knowledge graph.
| Gene Symbol | DES |
| Full Name | Desmin |
| Chromosome | 2q35 |
| Function | is a critical structural component of muscle cells[@paulin2004]. |
| Molecular Weight | 53 kDa |
| Amino Acids | 470 aa |
| Pathways | Angiogenesis, Apoptosis, Autophagy, Ferroptosis, Necroptosis |
| UniProt ID | P17661 |
| NCBI Gene ID | 1674 |
| Ensembl ID | ENSG00000175084 |
| OMIM | 125660 |
| GeneCards | DES |
| Human Protein Atlas | DES |
| N-terminal head domain (residues 1-99) | Contains phosphorylation sites and regulates filament assembly |
| Central rod domain (residues 100-411) | Consists of four alpha-helical segments (1A, 1B, 2A, 2B) separated by linkers, responsible for dimerization and filament assembly |
| Associated Diseases | Aging, Als, Alzheimer, Cancer, Cardiac, Cardiovascular |
| Interactions | MCU, BECN1, SLC7A11, RIPK1, FADD, NRP1 |
| KG Connections | 199 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
DES["<b>DES</b>"]
SMOC2["SMOC2"]
DES -->|"co expressed with"| SMOC2
DSP["DSP"]
DES -->|"co expressed with"| DSP
GJA1["GJA1"]
DES -->|"co expressed with"| GJA1
myofibrillar_myopathy{"myofibrillar myopathy"}
DES -->|"causes"| myofibrillar_myopathy
Aging{"Aging"}
DES -->|"activates"| Aging
Ms{"Ms"}
DES -->|"activates"| Ms
Cancer{"Cancer"}
DES -->|"associated with"| Cancer
Als{"Als"}
DES -->|"therapeutic target"| Als
DES -->|"therapeutic target"| Aging
Tumor{"Tumor"}
DES -->|"therapeutic target"| Tumor
Longevity{"Longevity"}
DES -->|"therapeutic target"| Longevity
DES -->|"associated with"| Ms
MCU["MCU"]
MCU -->|"activates"| DES
SLC7A11["SLC7A11"]
SLC7A11 -->|"activates"| DES
BECN1["BECN1"]
BECN1 -->|"activates"| DES
GENES["GENES"]
GENES -->|"therapeutic target"| DES
AMPK["AMPK"]
AMPK -->|"activates"| DES
ABCB1["ABCB1"]
ABCB1 -->|"associated with"| DES
FAS["FAS"]
FAS -->|"interacts with"| DES
CASP8["CASP8"]
CASP8 -->|"interacts with"| DES
CASP6["CASP6"]
CASP6 -->|"interacts with"| DES
MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"]
MITOCHONDRIAL_DYSFUNCTION -->|"activates"| DES
APOPTOSIS["APOPTOSIS"]
APOPTOSIS -->|"activates"| DES
CANCER["CANCER"]
CANCER -->|"associated with"| DES
style DES fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Myofibrillar Myopathy | causes | disease | 0.95 |
| GJA1 | co_expressed_with | gene | 0.80 |
| SMOC2 | co_expressed_with | gene | 0.80 |
| DSP | co_expressed_with | gene | 0.80 |
| Tumor | activates | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| myofibrillar myopathy | causes | disease | 0.70 |
| Aging | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Longevity | therapeutic_target | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Aging | expressed_in | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Aging | implicated_in | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Dementia | biomarker_for | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Tumor | biomarker_for | disease | 0.65 |
| Hepatocellular Carcinoma | biomarker_for | disease | 0.65 |
| Cancer | biomarker_for | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Carcinoma | biomarker_for | disease | 0.65 |
| Cirrhosis | implicated_in | disease | 0.65 |
| Fibrosis | implicated_in | disease | 0.65 |
| Hepatitis | implicated_in | disease | 0.65 |
| Diabetes | implicated_in | disease | 0.65 |
| Cardiovascular | implicated_in | disease | 0.65 |
| Hypertension | implicated_in | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Ischemia | implicated_in | disease | 0.65 |
| Cardiac | implicated_in | disease | 0.65 |
| Inflammation | contributes_to | disease | 0.65 |
| Obesity | implicated_in | disease | 0.65 |
| Insulin Resistance | implicated_in | disease | 0.65 |
| Hepatitis | protects_against | disease | 0.65 |
| Infection | protects_against | disease | 0.65 |
| Als | protects_against | disease | 0.65 |
| Pain | associated_with | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| MCU | activates | gene | 0.60 |
| SLC7A11 | activates | gene | 0.60 |
| BECN1 | activates | gene | 0.60 |
| ABCB1 | associated_with | gene | 0.60 |
| FAS | interacts_with | gene | 0.60 |
| CASP8 | interacts_with | gene | 0.60 |
| CASP6 | interacts_with | gene | 0.60 |
| VEGF | therapeutic_target | gene | 0.60 |
| TAU | biomarker_for | gene | 0.60 |
| BAD | therapeutic_target | gene | 0.60 |
| P38 | inhibits | gene | 0.60 |
| BRCA1 | degrades | entity | 0.60 |
| DNAJB6 | associated_with | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| FLNC | associated_with | gene | 0.60 |
| NBR1 | associated_with | gene | 0.60 |
| MYOT | associated_with | gene | 0.60 |
| P62 | associated_with | gene | 0.60 |
| BRCA1 | associated_with | gene | 0.60 |
| MACF1 | causes | gene | 0.60 |
| CHRNE | causes | gene | 0.60 |
| MACF1 | associated_with | gene | 0.60 |
| GENES | therapeutic_target | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| FERROPTOSIS | activates | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| AUTOPHAGY | implicated_in | gene | 0.60 |
| AGING | implicated_in | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| AMYLOID | associated_with | gene | 0.60 |
| DNA | biomarker_for | gene | 0.60 |
| CANCER | biomarker_for | gene | 0.60 |
| APOPTOSIS | contributes_to | gene | 0.60 |
| INSULIN RESISTANCE | implicated_in | gene | 0.60 |
| INFLAMMATION | contributes_to | gene | 0.60 |
| AND | interacts_with | gene | 0.60 |
| AND | protects_against | gene | 0.60 |
| AND | activates | gene | 0.60 |
| AGING | activates | gene | 0.60 |
| ONCOGENES | therapeutic_target | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| AGING | therapeutic_target | gene | 0.60 |
| AND | biomarker_for | gene | 0.60 |
| AGING | expressed_in | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| ONCOGENES | expressed_in | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| DAPK1 Inhibition as Dual-Mechanism Neuroprotection Against T | 0.579 | neurodegeneration | Should microtubule-stabilizing drugs be |
| Competitive APOE4 Domain Stabilization Peptides | 0.561 | neurodegeneration | APOE4 structural biology and therapeutic |
| Vascular mural cell degeneration precedes and exacerbates pa | 0.520 | Alzheimer's disease | SEA-AD Single-Cell Analysis: Cell-Type V |
| Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides | 0.509 | neurodegeneration | Blood-brain barrier transport mechanisms |
| Synthetic Biology Approach: Designer Mitochondrial Export Sy | 0.358 | neurodegeneration | Mitochondrial transfer between neurons a |
| Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m | 0.348 | neurodegeneration | Mitochondrial transfer between astrocyte |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.576
neuroinflammation | 2026-04-15 | 1 hypotheses Top: 0.650
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.609
neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.567
neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.596
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegenerat [PMID:37995685] | Litvinchuk A, Suh JH, Guo JL, Lin K, Dav | Neuron | 2024 | 1 |
| The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegene [PMID:37957317] | Maxine R Nelson, Peng Liu, Ayushi Agrawa | Nature neuroscience | 2023 | 1 |
| Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmon [PMID:35257044] | Calvier L, Herz J, Hansmann G | JACC Basic Transl Sci | 2022 | 1 |
| ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies. [PMID:36348357] | Raulin AC, Doss SV, Trottier ZA, Ikezu T | Mol Neurodegener | 2022 | 1 |
| APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therape [PMID:33340485] | Serrano-Pozo A, Das S, Hyman BT | Lancet Neurol | 2021 | 1 |
| Lysosome-targeting chimaeras for degradation of extracellular proteins. [PMID:32728216] | Banik SM, Pedram K, Wisnovsky S, Ahn G, | Nature | 2020 | 1 |
| Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventin [PMID:30595089] | Brophy ML, Dong Y, Tao H, Yancey PG, Son | Circ Res | 2019 | 1 |
| Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. [PMID:31564456] | Long JM, Holtzman DM | Cell | 2019 | 1 |
| KIF5A de novo mutation associated with myoclonic seizures and neonatal onset pro [PMID:27414745] | Rydzanicz M, Jagła M, Kosinska J, Tomasi | Clin Genet | 2017 | 1 |
| Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical [PMID:28381441] | Shinohara M, Tachibana M, Kanekiyo T, Bu | J Lipid Res | 2017 | 1 |
| TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and [PMID:23395375] | van Spronsen M, Mikhaylova M, Lipka J, S | Neuron | 2013 | 1 |
| Delineation of the TRAK binding regions of the kinesin-1 motor proteins. [PMID:24161670] | Randall TS, Moores C, Stephenson FA | FEBS Lett | 2013 | 1 |
| Integrating biocatalysis with continuous flow: current status, challenges, and f [PMID:40639553] | Bai J, Huang C, Liu Y, Zheng X, Liu J et | J Adv Res | 2026 | 0 |
| Engineering chimeric signaling proteins for microbial whole-cell biosensors: fro [PMID:40903364] | Özer Bergman G, Mecacci S, Martins Dos S | Trends Biotechnol | 2026 | 0 |
| MTAP Deletion in Oncogenesis: A Synthetic Lethality Scenario. [PMID:41512197] | Rodon J, Johnson ML, George B, Shah PA, | Cancer Res | 2026 | 0 |
| Engineering the Caenorhabditis elegans genome with a nested, self-excising selec [PMID:41557645] | Gibney TV, Pani AM | Genetics | 2026 | 0 |
| Design and synthesis of BAP-1 inhibitors. [PMID:41761813] | Zhang Z, Yang X | Pak J Pharm Sci | 2026 | 0 |
| Optimized bacterial expression of a synthetic BRIL antibody. [PMID:41842660] | Cooper BF, Isom GL | Acta Crystallogr F Struct Biol | 2026 | 0 |
| Chemogenetic Modulation of Luciferase Emission Color for Imaging and Sensing. [PMID:41941277] | Manirakiza H, Shpinov Y, Gontier A, El H | ACS Sens | 2026 | 0 |
| A Constrained Degron Tag Engineered to Enhance Auxin-Inducible Protein Degradati [PMID:41941339] | Han Z, Alkhadrawi A, Tofani S, Zhang W, | ACS Synth Biol | 2026 | 0 |